exRNAdisease

Entry Detail

---



General Information

Database ID: exR0267213 RNA Name: hsa-miR-367-3p RNA Type: miRNA Chromosome: chr4 Starnd: - Coordinate: Start Site(bp): 112647877 End Site(bp): 112647898 External Links: hsa-miR-367-3p

Disease Information

Disease Name: Cystic Fibrosis Disease Category: Congenital, Hereditary, and Neonatal Diseases and Abnormalities MeSH ID: D003550 Type: Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities Alias: Fibrosis, Cystic//Mucoviscidosis//Pulmonary Cystic Fibrosis//Cystic Fibrosis, Pulmonary//Pancreatic Cystic Fibrosis//Cystic Fibrosis, Pancreatic//Fibrocystic Disease of Pancreas//Pancreas Fibrocystic Disease//Pancreas Fibrocystic Diseases//Cystic Fibrosis of Pancreas

Expression Detail

GEO ID: GSE135119 Description: Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis Experimental Design: Disease vs Control Case Disease Type: Cystic Fibrosis Case Disease SubType: NA Case Sample: Cystic Fibrosis Control Sample: Healthy Number of Case: 5 Number of Control: 5 Number of Samples: 10

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand FHL1 chrX 136146702 136211359 + LRP12 chr8 104489231 104589024 - RALY chr20 33993646 34108308 + THOC2 chrX 123600561 123733056 - ACTB chr7 5527148 5563784 - DCP2 chr5 112976702 113022195 + PKM chr15 72199029 72231822 - METTL7A chr12 50923472 50932510 + CCNF chr16 2429394 2458854 + ATP6V1A chr3 113747033 113812056 + SELENOT chr3 150602875 150630445 + HSPA4 chr5 133052013 133106449 + EML4 chr2 42169353 42332548 + VIM chr10 17228241 17237593 + TRIM13 chr13 49995888 50020481 + MRS2 chr6 24402908 24426194 + SCML2 chrX 18239313 18354688 - CGN chr1 151510510 151538692 + NCAPD3 chr11 134150119 134225454 - ADCY9 chr16 3953387 4116442 - ZNF451 chr6 57086844 57170305 + SAR1B chr5 134601149 134649271 - CALM2 chr2 47160083 47176921 - CTNNB1 chr3 41194741 41260096 + NEK4 chr3 52708444 52770946 - IGSF8 chr1 160091340 160098943 - SH3PXD2A chr10 103594027 103855543 - RAB9A chrX 13689128 13710504 + TUBA1C chr12 49188736 49274603 + TMED10 chr14 75131469 75176612 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001005 chr2 53921020 53978078 - hsa_circ_0001414 chr4 56277780 56284152 + hsa_circ_0000126 chr1 150997086 150999803 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC005394.2 chr19 28435388 28727680 - AC008040.1 chr3 169939353 169966734 - AC074117.1 chr2 27356246 27367622 + AC130650.2 chr16 14150833 14153235 + DAPK1-IT1 chr9 87553454 87554459 + LINC01128 chr1 825138 859446 + MALAT1 chr11 65497688 65506516 + NORAD chr20 36045618 36051018 - OIP5-AS1 chr15 41283990 41309737 + PITPNA-AS1 chr17 1516931 1518096 + PURPL chr5 27217714 27496994 + SNHG5 chr6 85650491 85678932 - XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE135119 Sample Source: Blood Source Fraction: Plasma Platform: GPL19117 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2346 Sample treatment protocol: NA RNA Extract protocol: Frozen samples; Mixture with Trizol Reagent followed by extraction with RNA Clean and Concentrator kit. RNA library preparation protocol: Using the Affymetrix GeneChip miRNA 4.0 array, 8ul of plasma from each sample was labelled using FlashTag Biotin RNA Labelling kit.

Reference

PMID: 31664087 Title: Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis Author: Ideozu JE, Zhang X, Rangaraj V, McColley S, Levy H Journal: Sci Rep. 2019 Oct 29;9(1):15483. Description: we employed microarray technology to identify aberrantly expressed plasma ECmiRNAs in CF and elucidate the functional relevance of their targets.